+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals - A Global Market Overview

  • ID: 4769497
  • Report
  • Region: Global
  • 480 Pages
  • Industry Experts
1 of 6
The Global Biopharmaceuticals Market is Projected to grow by 8.7% Through to 2025 and Reach $446 Billion

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Astrazeneca Plc
  • Biological E Limited
  • Evotec AG
  • Merck & Co., Inc.
  • RPG Life Sciences Limited
  • MORE

The biopharmaceuticals market is driven by various factors, such as increase in elderly population, surge in prevalence of chronic diseases like cancer, HIV/AIDS and diabetes, and increase in adoption of biopharmaceuticals globally. Biopharmaceuticals offer several benefits including highly effective and potent action, fewer side effects, and the potential to actually cure diseases rather than merely treat the symptoms, which have significantly increased the demand for biopharmaceutical products. The market growth is attributed to the growing acceptance for biopharmaceuticals due to their ability to treat previously untreatable diseases, resulting in huge market demand for biopharmaceuticals.

Global demand for Biopharmaceuticals by product is led by Monoclonal Antibodies (moAb), estimated at US$82.3 billion (33.2% share) in 2018, and is also projected to witness the fastest CAGR of 10.8% between 2018 and 2025. The global market for biopharmaceuticals in 2019 is expected to reach US$269.3 billion.

Research Findings & Coverage

  • The Biopharmaceuticals global market explored in this study with respect to product types and application areas
  • The study extensively analyzes above mentioned product types and applications of Biopharmaceuticals in each major region/country globally for the analysis period
  • Lanadelumab Effective in Reducing Swelling Attacks in Patients with Hereditary Angioedema
  • Emerging Innovations and their Impact on Biopharma Manufacturing in the Coming Years
  • Monoclonal Antibodies Show High Potential Against Zika Virus Infection
  • Portable Bioreactor Produces Biopharmaceutical Drugs on Demand at a Point of Care
  • Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
  • Major companies profiled – 58
  • The industry guide includes the contact details for 843 companies

Product Outline

The report analyzes the market for the product types of Biopharmaceuticals including:

  • Monoclonal Antibodies (moAb)
  • Biotech Vaccines
  • Recombinant Human (RH) Insulin
  • Erythropoietin
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Interferons
  • Human Growth Hormones (HGH)
  • Other Biopharmaceuticals

Application Areas of Biopharmaceuticals analyzed comprise the following:

  • Oncology
  • Autoimmune Disorders
  • Diabetes
  • Inflammatory and Infectious Diseases
  • Neurological Diseases
  • Cardiovascular Diseases
  • Others

Analysis Period, Units and Growth Rates
The report reviews, analyzes and projects the global Biopharmaceuticals market for the period 2016-2025 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2018 through 2025

Geographic Coverage

  • North America (The United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Italy, Spain and Rest of Europe)
  • Asia-Pacific (Japan, China, India, South Korea and Rest of Asia-Pacific)
  • South America (Argentina, Brazil and Rest of South America)
  • Rest of World
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Astrazeneca Plc
  • Biological E Limited
  • Evotec AG
  • Merck & Co., Inc.
  • RPG Life Sciences Limited
  • MORE

Part A: Global Market Perspective

1. Introduction
1.1 Product Outline
1.1.1 Biopharmaceuticals
1.1.2 Evolution of the Biopharmaceuticals
1.1.3 Biosimilars
1.1.4 Commercialization of Biopharmaceuticals
1.1.5 Biopharmaceuticals Regulations
1.1.6 Production of Biopharmaceuticals
1.1.6.1 Microbial Cells
1.1.6.2 Mammalian Cells
1.1.6.3 Plant Cells
1.1.6.4 Transgenics
1.1.7 Disposable Manufacturing with Single-Use Systems
1.1.8 Characterization of Biopharmaceuticals
1.1.8.1 Circular Dichroism (CD)
1.1.8.2 Capillary Electrophoresis (CE)
1.1.8.3 Nuclear Magnetic Resonance (NMR)
1.1.8.4 Analytical Ultracentrifugation (AUC):
1.1.8.5 Differential Scanning Calorimetry (DSC)
1.1.8.6 Scattering Techniques
1.1.9 Delivery Systems for Biopharmaceuticals
1.1.9.1 Parenteral
1.1.9.2 Pulmonary Delivery
1.1.9.3 Nasal Delivery
1.1.9.4 Transdermal administration
1.1.9.5 Oral Delivery
1.1.9.6 Drug Targeting to Brain
1.1.10 Categorization of Biopharmaceuticals
1.1.10.1 Monoclonal Antibodies
1.1.10.1.1 Production of Monoclonal Antibodies
1.1.10.1.2 Primary Applications of Monoclonal Antibodies
1.1.10.1.3 Therapeutic Applications of Monoclonal Antibodies
1.1.10.1.3.1 Cancer
1.1.10.1.3.2 Autoimmune Diseases
1.1.10.1.4 Therapeutic Monoclonal Antibodies Approved by the FDA
1.1.10.2 Erythropoietin (EPO)
1.1.10.2.1 Functions of EPO
1.1.10.2.2 Medical Uses of EPO
1.1.10.2.3 Available Forms of EPO
1.1.10.3 Biotech Vaccines
1.1.10.3.1 Categories of Vaccines
1.1.10.3.2 Recombinant Vector Vaccines
1.1.10.3.3 Production of Recombinant Vector Vaccines
1.1.10.3.4 Positives and Negatives of Recombinant Vector Vaccines
1.1.10.4 Recombinant Human (RH) Insulin
1.1.10.4.1 Production of RH Insulin
1.1.10.5 Granulocyte Colony-Stimulating Factor (G-CSF)
1.1.10.5.1 Biological Role of G-CSF
1.1.10.5.2 Therapeutic Applications of G-CSF
1.1.10.5.3 Some Highlights of G-CSF
1.1.10.6 Interferons (IFNs)
1.1.10.6.1 Types of Interferons
1.1.10.6.2 Functions of Interferons
1.1.10.6.3 Disease Therapy with Interferons
1.1.10.6.4 Interferons and Drug Formulations
1.1.10.7 Human Growth Hormones
1.1.10.7.1 The Functioning of Human Growth Hormone
1.1.10.7.2 Clinical Importance of HGH
1.1.10.7.2.1 Excess of HGH
1.1.10.7.2.2 Deficiency of HGH
1.1.10.7.3 Use of HGH as a Medication
1.1.10.7.3.1 In Replacement Therapy
1.1.10.7.3.2 Additional Approved Applications
1.1.10.7.3.3 Off-Label Use of GH
1.1.10.7.3.4 Side Effects of GH Therapy
1.1.10.8 Other Biopharmaceuticals
1.1.10.8.1 Blood Factors (Factor VIII and Factor IX)
1.1.10.8.1.1 Factor VIII
1.1.10.8.1.1.1 Therapeutic Applications of Factor VIII
1.1.10.8.1.2 Factor IX
1.1.10.8.1.2.1 The Function of Factor IX in Disease
1.1.10.8.2 Thrombolytic Agents (Tissue Plasminogen Activator)
1.1.10.8.2.1 Function of tPA
1.1.10.8.2.2 Clinical Uses of tPA
1.1.10.8.2.3 Recombinant Tissue Plasminogen Activators (rtPA)
1.1.10.8.3 Interleukin-Based Products
1.1.10.8.3.1 Human Interleukins
1.1.10.8.4 Tumor Necrosis Factor
1.1.10.8.5 Therapeutic Enzymes
1.1.10.8.5.1 A Few Important Therapeutic Enzymes

2. Key Market Trends
2.1 Pembrolizumab Prolongs Overall Survival in Recurrent, Metastatic Head and Neck Squamous Cell Carcinoma
2.2 Lanadelumab Effective in Reducing Swelling Attacks in Patients with Hereditary Angioedema
2.3 FDA and Other Federal Health Agencies to Address the Challenges in Developing New Antimicrobials
2.4 Isolated Human Monoclonal Antibodies that Neutralize Norovirus
2.5 Emerging Innovations and their Impact on Biopharma Manufacturing in the Coming Years
2.6 Monoclonal Antibodies Show High Potential Against Zika Virus Infection
2.7 Rapid Technological Advancements are Changing the Biopharmaceuticals Industry
2.8 Portable Bioreactor Produces Biopharmaceutical Drugs on Demand at a Point of Care

3. Key Global Players

  • Abbott Laboratories, Inc. (United States)
  • AbbVie Inc. (United States)
  • Amgen, Inc. (United States)
  • Astrazeneca Plc (United Kingdom)
  • Bayer AG (Germany)
  • Biocon Ltd. (India)
  • Biogen Inc (United States)
  • Boehringer Ingelheim GmbH (Germany)
  • Bristol-Myers Squibb Company (United States)
  • Eli Lilly and Company (United States)
  • Glaxosmithkline, Plc (United Kingdom)
  • Johnson & Johnson (United States)
  • Janssen Pharmaceuticals, Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Novartis AG (Switzerland)
  • Novo Nordisk, Inc. (United States)
  • Pfizer Inc (United States)
  • Regeneron Pharmaceuticals, Inc. (United States)
  • Roche Holding AG (Switzerland)
  • Genentech, Inc. (United States)
  • Sanofi (France)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • UCB S.A. (Belgium)

4. Key Business and Product Trends

  • Eli Lilly Acquires Loxo Oncology to expand its Oncology Portfolio
  • FDA Expands ALIMTA (Pemetrexed) Label with Combination of KEYTRUDA (Pembrolizumab) and Platinum Chemotherapy for the First-Line NSCLC Treatment
  • GlaxoSmithKline (GSK) Acquires TESARO, a Biopharmaceutical Company for $5.1 Billion
  • FDA Approves Adacel (Tdap) Vaccine for Repeat Vaccinations
  • Sanofi to Enter into License Agreement with Biomunex to Develop Antibody Therapeutics
  • AbSci and Sanofi to Enter into Manufacturing Partnership
  • Takeda Completes Acquisition of Shire Plc
  • 19 December 2018Biogen Collaborates With C4 Therapeutics to Develop Treatments for Neurological Conditions
  • Abbvie to Collaborate With Tizona to Develop Antibody Immunotherapy
  • Bristol-Myers Squibb to Acquire Celgene for $74-Billion
  • FDA Approved Sprycel® (Dasatinib) Tablets in Combination with Chemotherapy in Certain Pediatric Patients
  • Novartis to Acquires Endocyte, a US-based biopharmaceutical company for $2.1 Billion
  • Abbvie Submits NDA to FDA and MAA to EMA for Upadacitinib
  • GSK and Pfizer to Merge Consumer Healthcare Businesses to Form a Joint Venture
  • Lilly Signs Research Collaboration and License Agreement with Aduro Biotech
  • Lilly to Acquire Hydra’s Pre-Clinical Pain Program TRPA1
  • Roche Subsidiary Genentech to Acquire NASH-Focused Jecure Therapeutics
  • Pfizer Gains Global Patent License for AbbVie’s HUMIRA® (Adalimumab)
  • Amgen and Provention Bio Enters Into Co-Development Agreement
  • Astrazeneca to Sell Synagis US Rights to Sobi for $1.5 Billion
  • Lilly Partners with NextCure to Develop Immuno-Oncology Medicines
  • AstraZeneca’s MedImmune Expands Innate Pharma Oncology Collaboration
  • Abbvie Teams Up With Morphic Therapeutic For Fibrotic Disease Treatments
  • Roche to Acquire Immuno-Oncology Company Tusk Therapeutics
  • Janssen Partners With Arrowhead to Treat Hepatitis B
  • Merck to collaborate with Dragonfly Therapeutics on Solid-Tumor Immunotherapies
  • Sanofi to Enter Research Collaboration with Dyadic
  • Pfizer Teams Up With BioNTech to Develop mRNA -Based Flu Vaccines for Prevention of Influenza
  • Amgen to Build Next-Generation Biomanufacturing Plant Rhode Island
  • Takeda Pharmaceutical to Acquire TiGenix, a Biopharmaceutical Company
  • GSK Signs R&D Partnership with 23andme
  • Novartis Inks $1.1 Billion Monoclonal Antibody Deal With MorphoSys and Galapagos
  • Novartis Partners With CELLforCURE to Manufacture CAR-T Therapies
  • Abbvie and Calico Collaborated to Develop T-Cell Therapies for Cancer
  • Sanofi to Partner with Translate Bio $850 Million mRNA Vaccine Development Deal
  • Sanofi to Acquire Ablynx in $4.8 Billion Deal
  • Alexion Teams Up With Complement to Treat Neurodegenerative Disorders
  • WuXi Biologics to Invest $60 Million in US Plant
  • FDA Approval for Samsung BioLogics’s mab Drug Substance Manufacturing Plant
  • Novartis to Acquire AveXis, Gene-Therapy Biotech Company for $8.7 Billion
  • Lilly to Buy ARMO Biosciences
  • Janssen Biotech to Acquire BeneVir Biopharm
  • Merck to Expand mRNA Cancer Vaccines Collaboration with Moderna
  • Janssen to Collaborate With Bristol-Myers Squibb to Develop Factor XIa (FXIa) Inhibitors
  • Alexion to Buy Sweden-Based Wilson Therapeutics
  • Lilly to Partner with Sigilon to Develop Encapsulated Cell Therapies
  • Boehringer Ingelheim Inks $1.7 Billion Immuno-Oncology Deal With OSE Immunotherapeutics
  • Pfizer to Enter Asset Contribution Agreement with Allogene Therapeutics
  • Sanofi to Acquire Biogen’s Bioverativ, a Hemophilia-focused company
  • AstraZeneca’s MedImmune to Spins off Biotech Company Focused on Autoimmune Diseases
  • Abbvie to Sign Strategic Collaboration with Alector Partner on Alzheimer’s Disease Immunotherapies
  • Lilly and CureVac Inks $1.8 Billion Deal to Develop mRNA Cancer Vaccines
  • J&J Terminates Two Drugs Sirukumab and Talacotuzumab from Pipeline
  • J&J’s Stelara Received FDA Approval for Expanded Indication
  • AbbVie and BMS Partners on clinical research collaboration
  • J&J to Enter R&D Partnership with Health and Human Services (HHS)

5. Recent Biopharmaceuticals Approvals

6. Global Market Overview
6.1 Global Biopharmaceuticals Market Overview by Product Type
6.1.1 Global Biopharmaceuticals Product Market Overview by Geographic Region
6.1.1.1 Monoclonal Antibodies (moAb)
6.1.1.2 Biotech Vaccines
6.1.1.3 Recombinant Human (RH) Insulin
6.1.1.4 Erythropoietin
6.1.1.5 Granulocyte Colony-Stimulating Factor (G-CSF)
6.1.1.6 Interferons
6.1.1.7 Human Growth Hormones (HGH)
6.1.1.8 Other Biopharmaceuticals
6.2 Global Biopharmaceuticals Market Overview by Application
6.2.1 Global Biopharmaceuticals Application Market Overview by Geographic Region
6.2.1.1 Oncology
6.2.1.2 Autoimmune Disorders
6.2.1.3 Diabetes
6.2.1.4 Inflammatory and Infectious Diseases
6.2.1.5 Neurological Diseases
6.2.1.6 Cardiovascular Diseases
6.2.1.7 Other Applications

Part B: Regional Market Perspective

Regional Market Overview

7. North America
7.1 North American Biopharmaceuticals Market Overview by Geographic Region
7.2 North American Biopharmaceuticals Market Overview by Product Type
7.2.1 Biopharmaceuticals Product Segment Market Overview by NA Region
7.2.1.1 Monoclonal Antibodies (moAb)
7.2.1.2 Biotech Vaccines
7.2.1.3 Recombinant Human (RH) Insulin
7.2.1.4 Erythropoietin
7.2.1.5 Granulocyte Colony-Stimulating Factor (G-CSF)
7.2.1.6 Interferons
7.2.1.7 Human Growth Hormones (HGH)
7.2.1.8 Other Biopharmaceuticals
7.3 North American Biopharmaceuticals Market Overview by Application
7.3.1 Biopharmaceuticals Application Market Overview by NA Region
7.3.1.1 Oncology
7.3.1.2 Autoimmune Disorders
7.3.1.3 Diabetes
7.3.1.4 Inflammatory and Infectious Diseases
7.3.1.5 Neurological Diseases
7.3.1.6 Cardiovascular Diseases
7.3.1.7 Other Applications
7.4 Major Market Players

  • Abbott Laboratories, Inc. (United States)
  • AbbVie Inc. (United States)
  • Alder Biopharmaceuticals Inc. (United States)
  • Alexion Pharmaceuticals, Inc (United States)
  • Amgen, Inc. (United States)
  • Analytical Biological Services Inc (United States)
  • Array Biopharma Inc. (United States)
  • Atlanta Biologicals, Inc (United States)
  • Biogen Inc (United States)
  • Bristol-Myers Squibb Company (United States)
  • Charles River Laboratories International, Inc. (United States)
  • Eli Lilly and Company (United States)
  • Fujifilm Diosynth Biotechnologies USA Inc (United States)
  • Genentech, Inc. (United States)
  • Johnson & Johnson (United States)
  • Janssen Pharmaceuticals, Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Millennium Pharmaceuticals, Inc. (United States)
  • Novo Nordisk, Inc. (United States)
  • Pfizer Inc (United States)
  • Regeneron Pharmaceuticals, Inc. (United States)
  • Sanofi-Aventis U.S. LLC (United States)
  • Seattle Genetics, Inc (United States)
  • Soligenix, Inc. (United States)
  • Sunovion Pharmaceuticals Inc. (United States)

7.5 Country-wise Analysis of North American Biopharmaceuticals Market
7.5.1 The United States
7.5.1.1 United States Biopharmaceuticals Market Overview by Product Type
7.5.1.2 United States Biopharmaceuticals Market Overview by Application
7.5.2 Canada
7.5.2.1 Canadian Biopharmaceuticals Market Overview by Product Type
7.5.2.2 Canadian Biopharmaceuticals Market Overview by Application
7.5.3 Mexico
7.5.3.1 Mexican Biopharmaceuticals Market Overview by Product Type
7.5.3.2 Mexican Biopharmaceuticals Market Overview by Application

8. Europe
8.1 European Biopharmaceuticals Market Overview by Geographic Region
8.2 European Biopharmaceuticals Market Overview by Product Type
8.2.1 Biopharmaceuticals Product Segment Market Overview by EU Region
8.2.1.1 Monoclonal Antibodies (moAb)
8.2.1.2 Biotech Vaccines
8.2.1.3 Recombinant Human (RH) Insulin
8.2.1.4 Erythropoietin
8.2.1.5 Granulocyte Colony-Stimulating Factor (G-CSF)
8.2.1.6 Interferons
8.2.1.7 Human Growth Hormones (HGH)
8.2.1.8 Other Biopharmaceuticals
8.3 European Biopharmaceuticals Market Overview by Application
8.3.1 Biopharmaceuticals Application Market Overview by EU Region
8.3.1.1 Oncology
8.3.1.2 Autoimmune Disorders
8.3.1.3 Diabetes
8.3.1.4 Inflammatory and Infectious Diseases
8.3.1.5 Neurological Diseases
8.3.1.6 Cardiovascular Diseases
8.3.1.7 Other Applications
8.4 Major Market Players

  • 3P Biopharmaceuticals S.L. (Spain)
  • Applikon Biotechnology B.V. (The Netherlands)
  • Albumedix Ltd. (United Kingdom)
  • Astrazeneca Plc (United Kingdom)
  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Cellgenix GmbH (Germany)
  • Evotec AG (Germany)
  • Glaxosmithkline, Plc (United Kingdom)
  • Novartis AG (Switzerland)
  • Roche Holding AG (Switzerland)
  • Sanofi (France)
  • UCB S.A. (Belgium)

8.5 Country-wise Analysis of European Biopharmaceuticals Market
8.5.1 Germany
8.5.1.1 German Biopharmaceuticals Market Overview by Product Type
8.5.1.2 German Biopharmaceuticals Market Overview by Application
8.5.2 France
8.5.2.1 French Biopharmaceuticals Market Overview by Product Type
8.5.2.2 French Biopharmaceuticals Market Overview by Application
8.5.3 The United Kingdom
8.5.3.1 United Kingdom Biopharmaceuticals Market Overview by Product Type
8.5.3.2 United Kingdom Biopharmaceuticals Market Overview by Application
8.5.4 Italy
8.5.4.1 Italy Biopharmaceuticals Market Overview by Product Type
8.5.4.2 Italy Biopharmaceuticals Market Overview by Application
8.5.5 Spain
8.5.5.1 Spanish Biopharmaceuticals Market Overview by Product Type
8.5.5.2 Spanish Biopharmaceuticals Market Overview by Application
8.5.6 Rest of Europe
8.5.6.1 Rest of Europe Biopharmaceuticals Market Overview by Product Type
8.5.6.2 Rest of Europe Biopharmaceuticals Market Overview by Application

9. Asia-Pacific
9.1 Asia-Pacific Biopharmaceuticals Market Overview by Geographic Region
9.2 Asia-Pacific Biopharmaceuticals Market Overview by Product Type
9.2.1 Biopharmaceuticals Product Segment Market Overview by Asia-Pacific Region
9.2.1.1 Monoclonal Antibodies (moAb)
9.2.1.2 Biotech Vaccines
9.2.1.3 Recombinant Human (RH) Insulin
9.2.1.4 Erythropoietin
9.2.1.5 Granulocyte Colony-Stimulating Factor (G-CSF)
9.2.1.6 Interferons
9.2.1.7 Human Growth Hormones (HGH)
9.2.1.8 Other Biopharmaceuticals
9.3 Asia-Pacific Biopharmaceuticals Market Overview by Application
9.3.1 Biopharmaceuticals Application Market Overview by Asia-Pacific Region
9.3.1.1 Oncology
9.3.1.2 Autoimmune Disorders
9.3.1.3 Diabetes
9.3.1.4 Inflammatory and Infectious Diseases
9.3.1.5 Neurological Diseases
9.3.1.6 Cardiovascular Diseases
9.3.1.7 Other Biopharmaceutical Applications
9.4 Major Market Players

  • Beijing SL Pharmaceutical Co Ltd (China)
  • Beijing Tiantan Biological Products Co Ltd (China)
  • Biocon Ltd. (India)
  • Biological E Limited (India)
  • Cadila Healthcare Limited (Zydus Cadila) (India)
  • Celltrion, Inc. (South Korea)
  • Glenmark Pharmaceuticals Limited (India)
  • GVK Biosciences Pvt Ltd (India)
  • Hualan Biological Engineering Inc (China)
  • Reliance Life Sciences Pvt Ltd (India)
  • RPG Life Sciences Limited (India)
  • Samsung Biologics Co Ltd (South Korea)
  • Shanghai Institute of Biological Products (China)
  • Shantha Biotechnics Ltd (India)
  • Sun Pharmaceutical Industries Ltd (India)
  • Suven Life Sciences Ltd (India)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Torrent Pharmaceuticals Limited (India)

9.5 Country-wise Analysis of Asia-Pacific Biopharmaceuticals Market
9.5.1 Japan
9.5.1.1 Japanese Biopharmaceuticals Market Overview by Product Type
9.5.1.2 Japanese Biopharmaceuticals Market Overview by Application
9.5.2 China
9.5.2.1 Chinese Biopharmaceuticals Market Overview by Product Type
9.5.2.2 Chinese Biopharmaceuticals Market Overview by Application
9.5.3 India
9.5.3.1 Indian Biopharmaceuticals Market Overview by Product Type
9.5.3.2 Indian Biopharmaceuticals Market Overview by Application
9.5.4 South Korea
9.5.4.1 South Korean Biopharmaceuticals Market Overview by Product Type
9.5.4.2 South Korean Biopharmaceuticals Market Overview by Application
9.5.5 Rest of Asia-Pacific
9.5.5.1 Rest of Asia-Pacific Biopharmaceuticals Market Overview by Product Type
9.5.5.2 Rest of Asia-Pacific Biopharmaceuticals Market Overview by Application

10. South America
10.1 South American Biopharmaceuticals Market Overview by Geographic Region
10.2 South American Biopharmaceuticals Market Overview by Product Type
10.2.1 Biopharmaceuticals Product Segment Market Overview by SA Region
10.2.1.1 Monoclonal Antibodies (moAb)
10.2.1.2 Biotech Vaccines
10.2.1.3 Recombinant Human (RH) Insulin
10.2.1.4 Erythropoietin
10.2.1.5 Granulocyte Colony-Stimulating Factor (G-CSF)
10.2.1.6 Interferons
10.2.1.7 Human Growth Hormones (HGH)
10.2.1.8 Other Biopharmaceuticals
10.3 South American Biopharmaceuticals Market Overview by Application
10.3.1 Biopharmaceuticals Application Market Overview by SA Region
10.3.1.1 Oncology
10.3.1.2 Autoimmune Disorders
10.3.1.3 Diabetes
10.3.1.4 Inflammatory and Infectious Diseases
10.3.1.5 Neurological Diseases
10.3.1.6 Cardiovascular Diseases
10.3.1.7 Other Applications
10.4 Country-wise Analysis of South American Biopharmaceuticals Market
10.4.1 Brazil
10.4.1.1 Brazilian Biopharmaceuticals Market Overview by Product Type
10.4.1.2 Brazilian Biopharmaceuticals Market Overview by Application
10.4.2 Argentina
10.4.2.1 Argentinean Biopharmaceuticals Market Overview by Product Type
10.4.2.2 Argentinean Biopharmaceuticals Market Overview by Application
10.4.3 Rest of South America
10.4.3.1 Rest of South America Biopharmaceuticals Market Overview by Product Type
10.4.3.2 Rest of South America Biopharmaceuticals Market Overview by Application

11. Rest of World
11.1 Rest of World Biopharmaceuticals Market Overview by Product Type
11.2 Rest of World Biopharmaceuticals Market Overview by Application
11.3 Major Market Players

  • Teva Pharmaceutical Industries Ltd. (Israel)
  • UNV Medicine Ltd. (Israel)

Part C: Guide To The Industry

  1. North America
  2. Europe
  3. Asia-Pacific
  4. Rest of World

Part D: Annexure

  1. Research Methodology
  2. Feedback

Charts & Graphs

Part A: Global Market Perspective
Chart 1: Global Biopharmaceuticals Market (2018 & 2025) by Geographic Region
Chart 2: Global Biopharmaceuticals Market (2018 & 2025) by Product
Chart 3: Global Biopharmaceuticals Market (2018 & 2025) by Application
Chart 4: Global Biopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 5: Global Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 6: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 7: Global Monoclonal Antibodies (moAb) Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 8: Glance at 2016, 2019 and 2025 Global Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 9: Global Biotech Vaccines Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 10: Glance at 2016, 2019 and 2025 Global Biotech Vaccines Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 11: Global Recombinant Human (RH) Insulin Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 12: Glance at 2016, 2019 and 2025 Global Recombinant Human (RH) Insulin Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 13: Global Erythropoietin Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 14: Glance at 2016, 2019 and 2025 Global Erythropoietin Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 15: Global Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 16: Glance at 2016, 2019 and 2025 Global Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 17: Global Interferons Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 18: Glance at 2016, 2019 and 2025 Global Interferons Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 19: Global Human Growth Hormones (HGH) Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 20: Glance at 2016, 2019 and 2025 Global Human Growth Hormones (HGH) Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 21: Global Other Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 22: Glance at 2016, 2019 and 2025 Global Other Biopharmaceuticals Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 23: Global Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 24: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others
Chart 25: Global Biopharmaceuticals in Oncology Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 26: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Oncology Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 27: Global Biopharmaceuticals in Autoimmune Disorders Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 28: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Autoimmune Disorders Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 29: Global Biopharmaceuticals in Diabetes Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 30: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Diabetes Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 31: Global Biopharmaceuticals in Inflammatory and Infectious Diseases Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 32: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Inflammatory and Infectious Diseases Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 33: Global Biopharmaceuticals in Neurological Diseases Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 34: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Neurological Diseases Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 35: Global Biopharmaceuticals in Cardiovascular Diseases Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 36: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Cardiovascular Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 37: Global Biopharmaceuticals in Other Applications Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 38: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Other Applications Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World

Part B: Regional Market Perspective
Chart 39: Global Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 40: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World

Regional Market Overview

North America
Chart 41: North American Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 42: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 43: North American Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 44: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 45: North American Monoclonal Antibodies (moAb) Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 46: Glance at 2016, 2019 and 2025 North American Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 47: North American Biotech Vaccines Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 48: Glance at 2016, 2019 and 2025 North American Biotech Vaccines Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 49: North American Recombinant Human (RH) Insulin Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 50: Glance at 2016, 2019 and 2025 North American Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 51: North American Erythropoietin Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 52: Glance at 2016, 2019 and 2025 North American Erythropoietin Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 53: North American Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 54: Glance at 2016, 2019 and 2025 North American Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 55: North American Interferons Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 56: Glance at 2016, 2019 and 2025 North American Interferons Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 57: North American Human Growth Hormones (HGH) Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 58: Glance at 2016, 2019 and 2025 North American Human Growth Hormones (HGH) Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 59: North American Other Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 60: Glance at 2016, 2019 and 2025 North American Other Biopharmaceuticals Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 61: North American Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 62: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others
Chart 63: North American Biopharmaceuticals in Oncology Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 64: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Oncology Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 65: North American Biopharmaceuticals in Autoimmune Disorders Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 66: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Autoimmune Disorders Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 67: North American Biopharmaceuticals in Diabetes Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 68: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Diabetes Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 69: North American Biopharmaceuticals in Inflammatory and Infectious Diseases Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 70: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Inflammatory and Infectious Diseases Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 71: North American Biopharmaceuticals in Neurological Diseases Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 72: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Neurological Diseases Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 73: North American Biopharmaceuticals in Cardiovascular Diseases Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 74: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Cardiovascular Diseases Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 75: North American Biopharmaceuticals in Other Applications Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 76: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Other Applications Market Share (%) by Geographic Region - United States, Canada and Mexico

The United States
Chart 77: United States Biopharmaceuticals Market Analysis (2016-2025) by Product Segment – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 78: Glance at 2016, 2019 and 2025 United States Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 79: United States Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 80: Glance at 2016, 2019 and 2025 United States Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Canada
Chart 81: Canadian Biopharmaceuticals Market Analysis (2016-2025) by Product Segment – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 82: Glance at 2016, 2019 and 2025 Canadian Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 83: Canadian Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 84: Glance at 2016, 2019 and 2025 Canadian Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Mexico
Chart 85: Mexican Biopharmaceuticals Market Analysis (2016-2025) by Product Segment – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 86: Glance at 2016, 2019 and 2025 Mexican Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 87: Mexican Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 88: Glance at 2016, 2019 and 2025 Mexican Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Europe
Chart 89: European Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 90: Glance at 2016, 2019 and 2025 European Biopharmaceuticals Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 91: European Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 92: Glance at 2016, 2019 and 2025 European Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 93: European Monoclonal Antibodies (moAb) Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 94: Glance at 2016, 2019 and 2025 European Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 95: European Biotech Vaccines Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 96: Glance at 2016, 2019 and 2025 European Biotech Vaccines Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 97: European Recombinant Human (RH) Insulin Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 98: Glance at 2016, 2019 and 2025 European Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 99: European Erythropoietin Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 100: Glance at 2016, 2019 and 2025 European Erythropoietin Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 101: European Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 102: Glance at 2016, 2019 and 2025 European Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 103: European Interferons Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 104: Glance at 2016, 2019 and 2025 European Interferons Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 105: European Human Growth Hormones (HGH) Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 106: Glance at 2016, 2019 and 2025 European Human Growth Hormones (HGH) Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 107: European Other Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 108: Glance at 2016, 2019 and 2025 European Other Biopharmaceuticals Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 109: European Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 110: Glance at 2016, 2019 and 2025 European Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others
Chart 111: European Biopharmaceuticals in Oncology Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 112: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Oncology Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 113: European Biopharmaceuticals in Autoimmune Disorders Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 114: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Autoimmune Disorders Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 115: European Biopharmaceuticals in Diabetes Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 116: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Diabetes Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 117: European Biopharmaceuticals in Inflammatory and Infectious Diseases Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 118: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Inflammatory and Infectious Diseases Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 119: European Biopharmaceuticals in Neurological Diseases Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 120: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Neurological Diseases Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 121: European Biopharmaceuticals in Cardiovascular Diseases Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 122: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Cardiovascular Diseases Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 123: European Biopharmaceuticals in Other Applications Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 124: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Other Applications Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe

Germany
Chart 125: German Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 126: Glance at 2016, 2019 and 2025 German Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 127: German Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 128: Glance at 2016, 2019 and 2025 German Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

France
Chart 129: French Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 130: Glance at 2016, 2019 and 2025 French Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 131: French Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 132: Glance at 2016, 2019 and 2025 French Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

The United Kingdom
Chart 133: United Kingdom Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 134: Glance at 2016, 2019 and 2025 United Kingdom Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 135: United Kingdom Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 136: Glance at 2016, 2019 and 2025 United Kingdom Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Italy
Chart 137: Italian Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 138: Glance at 2016, 2019 and 2025 Italian Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 139: Italian Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 140: Glance at 2016, 2019 and 2025 Italian Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Spain
Chart 141: Spanish Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 142: Glance at 2016, 2019 and 2025 Spanish Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 143: Spanish Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 144: Glance at 2016, 2019 and 2025 Spanish Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Rest of Europe
Chart 145: Rest of Europe Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 146: Glance at 2016, 2019 and 2025 Rest of Europe Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 147: Rest of Europe Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 148: Glance at 2016, 2019 and 2025 Rest of Europe Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Asia-Pacific
Chart 149: Asia-Pacific Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 150: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 151: Asia-Pacific Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 152: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 153: Asia-Pacific Monoclonal Antibodies (moAb) Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 154: Glance at 2016, 2019 and 2025 Asia-Pacific Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 155: Asia-Pacific Biotech Vaccines Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 156: Glance at 2016, 2019 and 2025 Asia-Pacific Biotech Vaccines Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 157: Asia-Pacific Recombinant Human (RH) Insulin Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 158: Glance at 2016, 2019 and 2025 Asia-Pacific Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 159: Asia-Pacific Erythropoietin Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 160: Glance at 2016, 2019 and 2025 Asia-Pacific Erythropoietin Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 161: Asia-Pacific Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 162: Glance at 2016, 2019 and 2025 Asia-Pacific Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 163: Asia-Pacific Interferons Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 164: Glance at 2016, 2019 and 2025 Asia-Pacific Interferons Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 165: Asia-Pacific Human Growth Hormones (HGH) Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 166: Glance at 2016, 2019 and 2025 Asia-Pacific Human Growth Hormones (HGH) Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 167: Asia-Pacific Other Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 168: Glance at 2016, 2019 and 2025 Asia-Pacific Other Biopharmaceuticals Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 169: Asia-Pacific Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 170: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others
Chart 171: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Oncology Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 172: Asia-Pacific Biopharmaceuticals in Oncology Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 173: Asia-Pacific Biopharmaceuticals in Autoimmune Disorders Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 174: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Autoimmune Disorders Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 175: Asia-Pacific Biopharmaceuticals in Diabetes Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 176: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Diabetes Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 177: Asia-Pacific Biopharmaceuticals in Inflammatory and Infectious Diseases Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 178: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Inflammatory and Infectious Diseases Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 179: Asia-Pacific Biopharmaceuticals in Neurological Diseases Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 180: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Neurological Diseases Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 181: Asia-Pacific Biopharmaceuticals in Cardiovascular Diseases Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 182: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Cardiovascular Diseases Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 183: Asia-Pacific Biopharmaceuticals in Other Applications Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 184: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Other Applications Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific

Japan
Chart 185: Japanese Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 186: Glance at 2016, 2019 and 2025 Japanese Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 187: Japanese Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 188: Glance at 2016, 2019 and 2025 Japanese Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

China
Chart 189: Chinese Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 190: Glance at 2016, 2019 and 2025 Chinese Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 191: Chinese Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 192: Glance at 2016, 2019 and 2025 Chinese Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

India
Chart 193: Indian Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 194: Glance at 2016, 2019 and 2025 Indian Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 195: Indian Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 196: Glance at 2016, 2019 and 2025 Indian Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

South Korea
Chart 197: South Korean Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 198: Glance at 2016, 2019 and 2025 South Korean Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 199: South Korean Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 200: Glance at 2016, 2019 and 2025 South Korean Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Rest of Asia-Pacific
Chart 201: Rest of Asia-Pacific Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 202: Glance at 2016, 2019 and 2025 Rest of Asia-Pacific Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 203: Rest of Asia-Pacific Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 204: Glance at 2016, 2019 and 2025 Rest of Asia-Pacific Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

South America
Chart 205: South American Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 206: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 207: South American Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 208: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 209: South American Monoclonal Antibodies (moAb) Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 210: Glance at 2016, 2019 and 2025 South American Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 211: South American Biotech Vaccines Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 212: Glance at 2016, 2019 and 2025 South American Biotech Vaccines Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 213: South American Recombinant Human (RH) Insulin Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 214: Glance at 2016, 2019 and 2025 South American Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 215: South American Erythropoietin Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 216: Glance at 2016, 2019 and 2025 South American Erythropoietin Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 217: South American Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 218: Glance at 2016, 2019 and 2025 South American Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 219: South American Interferons Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 220: Glance at 2016, 2019 and 2025 South American Interferons Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 221: South American Human Growth Hormones (HGH) Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 222: Glance at 2016, 2019 and 2025 South American Human Growth Hormones (HGH) Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 223: South American Other Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 224: Glance at 2016, 2019 and 2025 South American Other Biopharmaceuticals Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 225: South American Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 226: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others
Chart 227: South American Biopharmaceuticals in Oncology Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 228: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Oncology Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 229: South American Biopharmaceuticals in Autoimmune Disorders Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 230: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Autoimmune Disorders Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 231: South American Biopharmaceuticals in Diabetes Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 232: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Diabetes Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 233: South American Biopharmaceuticals in Inflammatory and Infectious Diseases Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 234: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Inflammatory and Infectious Diseases Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 235: South American Biopharmaceuticals in Neurological Diseases Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 236: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Neurological Diseases Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 237: South American Biopharmaceuticals in Cardiovascular Diseases Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 238: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Cardiovascular Diseases Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
Chart 239: South American Biopharmaceuticals in Other Applications Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
Chart 240: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Other Applications Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America

Brazil
Chart 241: Brazilian Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 242: Glance at 2016, 2019 and 2025 Brazilian Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 243: Brazilian Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 244: Glance at 2016, 2019 and 2025 Brazilian Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Argentina
Chart 245: Argentinean Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 246: Glance at 2016, 2019 and 2025 Argentinean Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 247: Argentinean Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 248: Glance at 2016, 2019 and 2025 Argentinean Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Rest of South America
Chart 249: Rest of South America Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 250: Glance at 2016, 2019 and 2025 Rest of South America Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 251: Rest of South America Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 252: Glance at 2016, 2019 and 2025 Rest of South America Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Rest of World
Chart 253: Rest of World Biopharmaceuticals Market Analysis (2016-2025) by Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
Chart 254: Glance at 2016, 2019 and 2025 Rest of World Biopharmaceuticals Market Share (%) by Product – Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
Chart 255: Rest of World Biopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
Chart 256: Glance at 2016, 2019 and 2025 Rest of World Biopharmaceuticals Market Share (%) by Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Tables:
Table 1: Anti-Inflammatory Monoclonal Antibodies
Table 2: Anti-Cancer Monoclonal Antibodies
Table 3: Other Monoclonal Antibodies
Table 4: Monoclonal Antibodies Approved by FDA
Table 5: Different Forms of Erythropoietin (EPO)
Table 6: Different Types of Human Interleukins
Table 7: Worldwide Approvals of Biopharmaceuticals through 2017 to 2019

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Astrazeneca Plc
  • Biological E Limited
  • Evotec AG
  • Merck & Co., Inc.
  • RPG Life Sciences Limited
  • MORE

Global Biopharmaceuticals Market is Projected to Grow by 8.7% through to 2025 and Reach $446 Billion.

The author published an updated 2019 version of the global market report on Biopharmaceuticals. As per the new report entitled "Biopharmaceuticals - A Global Market Overview", Oncology constitutes the largest, as also the fastest, growing application for Biopharmaceuticals globally, which is expected to register a CAGR of 10.6% over 2018-2025.

The report reviews, analyzes and projects the biopharmaceuticals market for the period 2016-2025 in terms of USD. Biopharmaceuticals product segments analyzed in this study comprises Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Others. Applications or therapeutic areas analyzed in this study comprises Oncology, Autoimmune Disorders, Diabetes, Inflammatory & Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others.

The global market for biopharmaceuticals is segmented into five regions namely, North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 14 independent countries across North America - The United States, Canada and Mexico; Europe - Germany, France, United Kingdom, Italy and Spain; Asia-Pacific - Japan, China, India and South Korea; and South America - Argentina and Brazil.

This 480 page global market report on Biopharmaceuticals includes 256 charts (includes a data table and graphical representation for each table), supported with a meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, product type and major application. This report includes the brief business profiles of 21 key global players and 58 major players across the North America - 25; Europe - 13; Asia-Pacific - 18; and Rest of World - 2. The report also provides the listing of the companies engaged in research & development, manufacturing and supply of Biopharmaceuticals. The global list of companies covers addresses, contact numbers and the website addresses of 843 companies.

Note: Product cover images may vary from those shown
5 of 6
  • 3P Biopharmaceuticals S.L.
  • AbbVie Inc.
  • Abbott Laboratories, Inc.
  • Albumedix Ltd.
  • Alder Biopharmaceuticals Inc.
  • Alexion Pharmaceuticals, Inc
  • Amgen, Inc.
  • Analytical Biological Services Inc
  • Applikon Biotechnology B.V.
  • Array Biopharma Inc.
  • Astrazeneca Plc
  • Atlanta Biologicals, Inc
  • Bayer AG
  • Beijing SL Pharmaceutical Co Ltd
  • Beijing Tiantan Biological Products Co Ltd
  • Biocon Ltd.
  • Biogen Inc
  • Biological E Limited
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Cadila Healthcare Limited (Zydus Cadila)
  • Cellgenix GmbH
  • Celltrion, Inc.
  • Charles River Laboratories International, Inc.
  • Eli Lilly and Company
  • Evotec AG
  • Fujifilm Diosynth Biotechnologies USA Inc
  • GVK Biosciences Pvt Ltd
  • Genentech, Inc.
  • Glaxosmithkline, Plc
  • Glenmark Pharmaceuticals Limited
  • Hualan Biological Engineering Inc
  • Janssen Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Millennium Pharmaceuticals, Inc.
  • Novartis AG
  • Novo Nordisk, Inc.
  • Pfizer Inc
  • RPG Life Sciences Limited
  • Regeneron Pharmaceuticals, Inc.
  • Reliance Life Sciences Pvt Ltd
  • Roche Holding AG
  • Samsung Biologics Co Ltd
  • Sanofi
  • Sanofi-Aventis U.S. LLC
  • Seattle Genetics, Inc
  • Shanghai Institute of Biological Products
  • Shantha Biotechnics Ltd
  • Soligenix, Inc.
  • Sun Pharmaceutical Industries Ltd
  • Sunovion Pharmaceuticals Inc.
  • Suven Life Sciences Ltd
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Limited
  • UCB S.A.
  • UNV Medicine Ltd.
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Order Online - visit: https://www.researchandmarkets.com/reports/4769497
Adroll
adroll